(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-3.32%) $1.920
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
2 days till quarter result
(bmo 2024-04-29)
Expected move: +/- 0.00%
0.72% KRW 111 900
Live Chart Being Loaded With Signals
Green Cross Corporation, a biopharmaceutical company, develops drugs and vaccines in South Korea. The company provides plasma derivatives, including albumin, immunoglobulin, and antithrombin; and vaccines for hepatitis-B, Hantavirus hemorrhagic fever, influenza, flu, and varicella...
Stats | |
---|---|
Dzisiejszy wolumen | 5 743.00 |
Średni wolumen | 20 520.00 |
Kapitalizacja rynkowa | 1 277.13B |
EPS | KRW0 ( 2024-02-11 ) |
Następna data zysków | ( KRW-197.50 ) 2024-04-29 |
Last Dividend | KRW0 ( N/A ) |
Next Dividend | KRW0 ( N/A ) |
P/E | 0 |
ATR14 | KRW242.53 (0.22%) |
Wolumen Korelacja
Green Cross Corporation Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Green Cross Corporation Korelacja - Waluta/Towar
Green Cross Corporation Finanse
Annual | 2023 |
Przychody: | KRW1 626.64B |
Zysk brutto: | KRW458.69B (28.20 %) |
EPS: | KRW-2 333.42 |
FY | 2023 |
Przychody: | KRW1 626.64B |
Zysk brutto: | KRW458.69B (28.20 %) |
EPS: | KRW-2 333.42 |
FY | 2022 |
Przychody: | KRW1 711.31B |
Zysk brutto: | KRW581.80B (34.00 %) |
EPS: | KRW5 734.87 |
FY | 2021 |
Przychody: | KRW1 537.83B |
Zysk brutto: | KRW520.59B (33.85 %) |
EPS: | KRW1 174.58 |
Financial Reports:
No articles found.
Green Cross Corporation
Green Cross Corporation, a biopharmaceutical company, develops drugs and vaccines in South Korea. The company provides plasma derivatives, including albumin, immunoglobulin, and antithrombin; and vaccines for hepatitis-B, Hantavirus hemorrhagic fever, influenza, flu, and varicella. It also offers prescription drugs for the bleeding symptom control and hemostasis for persons with hemophilia A; prevention and treatment of bleeding episodes induced by hemophilia A and post-operative treatment; and treatment of neutropenia, hunter syndrome, and liver cancer, as well as treatment of anti-inflammation, pain relief, and osteoarthritis. In addition, the company provides over the counter drugs. It also exports its products to approximately 50 countries. The company has a licensing and collaboration agreement with Tottori University for development of GM1 gangliosidosis chaperone therapy. The company was formerly known as Sudo Microorganism Medical Supplies Company and changed its name to Green Cross Corporation in 1971. Green Cross Corporation was founded in 1967 and is headquartered in Yongin-si, South Korea. Green Cross Corporation is a subsidiary of Green Cross Holdings Corporation.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej